# | Virksomhed | Resultat | Egenkapital | Ansatte | Kvinder | Konkurser |
---|---|---|---|---|---|---|
1 | NOVO NORDISK A/S (CVR 24256790 ) | 38.951.000.000 | 57.593.000.000 | 1000 | 27 % | 1 % |
2 | LEO PHARMA A/S (CVR 56759514 ) | 743.000.000 | 25.212.000.000 | 1000 | 42 % | 0 % |
3 | H. LUNDBECK A/S (CVR 56759913 ) | 2.667.000.000 | 14.554.000.000 | 1000 | 21 % | 0 % |
4 | ALK-ABELLÓ A/S (CVR 63717916 ) | 270.000.000 | 2.875.000.000 | 750 | 31 % | 1 % |
5 | BAVARIAN NORDIC A/S (CVR 16271187 ) | -346.777.000 | 1.865.455.000 | 350 | 0 % | 2 % |
6 | TAKEDA PHARMA A/S (CVR 16406899 ) | 84.680.112.000 | 1.314.274.000 | 350 | 0 % | 0 % |
7 | PHARMACOSMOS HOLDING A/S (CVR 69720919 ) | 50.722.000 | 940.077.000 | 0 % | 1 % | |
8 | AJ Vaccines A/S (CVR 37911143 ) | -244.490.000 | 903.163.000 | 750 | 0 % | 8 % |
9 | PHARMACOSMOS A/S (CVR 15517085 ) | 56.457.000 | 884.049.000 | 150 | 0 % | 1 % |
10 | Novo Nordisk Pharmatech A/S (CVR 13246149 ) | 105.268.000 | 614.221.000 | 150 | 33 % | 0 % |
11 | AGC Biologics A/S (CVR 25950941 ) | 154.328.000 | 316.811.000 | 350 | 0 % | 0 % |
12 | PHARMA NORD ApS (CVR 67303016 ) | 41.501.000 | 269.730.000 | 150 | 0 % | 10 % |
13 | SERA-SCANDIA A/S (CVR 14605185 ) | 23.358.000 | 63.227.000 | 7 | 0 % | 23 % |
14 | Bacthera Denmark A/S (CVR 40697322 ) | 1.502.000 | 53.083.000 | 0 % | 0 % | |
15 | MEABCO A/S (CVR 25881435 ) | -24.458.334 | 47.391.745 | 3 | 20 % | 5 % |
16 | SAMPLIX ApS (CVR 32309321 ) | -15.372.531 | 26.884.565 | 15 | 0 % | 4 % |
17 | Medican A/S (CVR 39015684 ) | -27.056.952 | 22.879.826 | 15 | 25 % | 4 % |
18 | SMARTPRACTICE DENMARK ApS (CVR 89669510 ) | 13.398.985 | 20.549.618 | 35 | 0 % | 0 % |
19 | REPONEX PHARMACEUTICALS A/S (CVR 30082346 ) | -1.853.921 | 14.933.340 | 1 | 40 % | 6 % |
20 | ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR 32323502 ) *) Valuta: EUR | 210.420 | 14.404.246 | 33 % | 9 % | |
21 | Aquaporin Membrane Proteins ApS (CVR 37407976 ) | 5.699.014 | 12.309.207 | 7 | 0 % | 1 % |
22 | Ascensia Diabetes Care Denmark ApS (CVR 36968591 ) | 3.059.490 | 11.953.790 | 7 | 100 % | 0 % |
23 | ELDON BIOLOGICALS A/S (CVR 26747007 ) | 3.309.735 | 10.451.740 | 7 | 0 % | 15 % |
24 | SCANPHARM A/S (CVR 16279099 ) | -2.876.360 | 9.867.009 | 75 | 17 % | 3 % |
25 | VIMINCO A/S (CVR 12245742 ) | -20.471.000 | 8.632.000 | 150 | 0 % | 0 % |
26 | ALLERGICA A/S (CVR 11919677 ) | 708.518 | 6.978.814 | 35 | 17 % | 0 % |
27 | ROS Therapeutics ApS (CVR 39507501 ) | -1.883.000 | 6.909.000 | 1 | 25 % | 4 % |
28 | PHARMAERO ApS (CVR 32827942 ) | -12.231.000 | 6.586.000 | 3 | 0 % | 0 % |
29 | FRED MANAGEMENT ApS (CVR 25329198 ) | -445.273 | 6.453.376 | 0 % | 8 % | |
30 | REPOCEUTICALS A/S (CVR 36494433 ) | -523.215 | 6.041.717 | 1 | 25 % | 6 % |
31 | HOSPIDANA ApS (CVR 87874818 ) | -340.573 | 5.827.607 | 15 | 0 % | 0 % |
32 | PEROZIN ApS (CVR 29183910 ) | 868.029 | 5.475.174 | 3 | 0 % | 0 % |
33 | HERTART ApS (CVR 32840787 ) | 870.027 | 5.130.597 | 0 % | 0 % | |
34 | SOLURAL PHARMA ApS (CVR 34724938 ) | 829.966 | 4.822.291 | 7 | 33 % | 0 % |
35 | PHYTORECEPTORS ApS (CVR 35820620 ) | 3.768.544 | 4.268.544 | 0 % | 0 % | |
36 | PHARMADAN A/S (CVR 26524938 ) | -799.804 | 2.635.144 | 33 % | 5 % | |
37 | Antag Therapeutics ApS (CVR 38402056 ) | -9.232.193 | 2.584.196 | 7 | 38 % | 0 % |
38 | ETO GARMENTS ApS (CVR 63814113 ) | 337.059 | 2.019.561 | 15 | 100 % | 0 % |
39 | MOTILITYCOUNT ApS (CVR 33498063 ) | -137.935 | 1.961.073 | 3 | 0 % | 12 % |
40 | OV-SPV2 ApS (CVR 38445928 ) | -1.238.000 | 1.667.000 | 0 % | 4 % | |
41 | GlyProVac ApS (CVR 39724758 ) | -917.733 | 1.370.867 | 3 | 67 % | 0 % |
42 | AKTIESELSKABET ROSCO (CVR 56052828 ) | 132.482 | 1.224.803 | 0 % | 0 % | |
43 | Pila Pharma Danmark ApS (CVR 39023636 ) | -2.101.576 | 909.492 | 100 % | 0 % | |
44 | Scanleaf ApS (CVR 39900351 ) | -130.515 | 871.485 | 0 % | 0 % | |
45 | MT-MicroSearch ApS (CVR 37812730 ) | 538.550 | 638.255 | 0 % | 22 % | |
46 | Tetramer Shop ApS (CVR 40243224 ) | 245.383 | 625.383 | 0 % | 0 % | |
47 | SCANDINAVIAN ASSET MANAGEMENT ApS (CVR 17559893 ) | -154.458 | 616.071 | 0 % | 0 % | |
48 | Inphena ApS (CVR 38793594 ) | -1.066.246 | 589.184 | 1 | 0 % | 14 % |
49 | GUNNAR KJEMS ApS (CVR 52893119 ) | 151.877 | 583.631 | 3 | 50 % | 5 % |
50 | Footprint Pharma ApS (CVR 37165174 ) | -367.563 | 532.437 | 100 % | 0 % | |
51 | Hallund CRC ApS (CVR 37592129 ) | -19.211 | 388.619 | 1 | 0 % | 0 % |
52 | NEUROLOGISK KLINIK ApS (CVR 31748429 ) | 144.705 | 375.994 | 1 | 0 % | 0 % |
53 | AKTIESELSKABET AF 1. JUNI 2011 I (CVR 33751540 ) | -16.590 | 347.556 | 0 % | 0 % | |
54 | Ciana Therapeutics ApS (CVR 40279865 ) | 264.429 | 314.429 | 0 % | 0 % | |
55 | HB MEDICAL SCANDINAVIA A/S (CVR 37638862 ) | -4.904.834 | 308.110 | 29 % | 4 % | |
56 | AddMe Consulting ApS (CVR 39791854 ) | 250.985 | 300.985 | 100 % | 0 % | |
57 | CiBiD Group ApS (CVR 38254855 ) | 388.405 | 239.518 | 3 | 0 % | 3 % |
58 | PK SOLUTIONS A/S (CVR 36185414 ) | -438.746 | 234.774 | 33 % | 18 % | |
59 | DeLiver Pharma ApS (CVR 39432714 ) | -12.094 | 219.581 | 0 % | 4 % | |
60 | EnteroTarget ApS (CVR 39315769 ) | -15.465 | 204.789 | 0 % | 0 % | |
61 | PRODUCT DEVELOPMENT SERVICE ApS (CVR 14827595 ) | 10.288 | 199.677 | 1 | 0 % | 0 % |
62 | CanFarm ApS (CVR 39174375 ) | -9.292 | 190.708 | 0 % | 9 % | |
63 | CORPORATEHEALTH INTERNATIONAL ApS (CVR 36539690 ) *) Valuta: EUR | 20.209 | 159.059 | 3 | 0 % | 24 % |
64 | STRAXFIX INTERNATIONAL ApS (CVR 33880200 ) | 3.857 | 137.769 | 0 % | 6 % | |
65 | 1stDrugResearch ApS (CVR 40927697 ) | 76.068 | 116.068 | 0 % | 0 % | |
66 | Inxo IVS (CVR 37758272 ) | -63 | 95.156 | 0 % | 13 % | |
67 | Tubular Technologies ApS (CVR 37933848 ) | -21.015 | 85.897 | 0 % | 33 % | |
68 | SYNAPTIC ApS (CVR 39746166 ) | -5.974 | 84.106 | 0 % | 0 % | |
69 | Nordic Pharma Lab ApS (CVR 39161672 ) | -11.668 | 76.992 | 50 % | 8 % | |
70 | Fit Future ApS (CVR 40563849 ) | -255 | 49.745 | 50 % | 0 % | |
71 | Clunas Innovation ApS (CVR 38715429 ) | -6.466 | 32.031 | 0 % | 0 % | |
72 | Zerion ApS (CVR 40169229 ) | -1.050.624 | 31.476 | 20 % | 11 % | |
73 | LiNA Medical Innovation ApS (CVR 36015535 ) | -3.437 | 30.527 | 0 % | 0 % | |
74 | AKI Therapeutics ApS (CVR 37509736 ) | -4.608 | 24.427 | 0 % | 7 % | |
75 | Galecteye Pharma ApS (CVR 38248243 ) | -6.020 | 14.777 | 50 % | 0 % | |
76 | DANVITAL ApS (CVR 34595062 ) | -24.040 | 9.350 | 50 % | 18 % | |
77 | LactaPure IVS (CVR 39683520 ) | 7.702 | 7.702 | 33 % | 0 % | |
78 | Tikun Olam Scandinavia ApS (CVR 39199467 ) | -40.996 | 4.710 | 0 % | 0 % | |
79 | Cordane IVS (CVR 39274698 ) | 1 | 50 % | 6 % | ||
80 | Ekstraco IVS (CVR 39567326 ) | 1 | 0 % | 0 % | ||
81 | Hadrup BioMed Holding IVS (CVR 38034871 ) | 1 | 100 % | 25 % | ||
82 | Netto Medicin IVS (CVR 38140353 ) | 1 | 0 % | 0 % | ||
83 | Nasal Innovation Systems ApS (CVR 37904724 ) | -21.650 | -2.005 | 0 % | 0 % | |
84 | Malakezi Holding IVS (CVR 39267527 ) | -5.425 | -2.425 | 0 % | 0 % | |
85 | Herbamin Biolab IVS (CVR 39573881 ) | -6.500 | -3.500 | 0 % | 21 % | |
86 | Fjord Pharmaceuticals IVS (CVR 38367188 ) | 636 | -7.019 | 50 % | 36 % | |
87 | Xtherapeutics IVS (CVR 37384089 ) | -7.500 | -7.499 | 0 % | 0 % | |
88 | Remecure IVS (CVR 40259724 ) | -9.204 | -9.104 | 100 % | 0 % | |
89 | AsoGen Therapeutics IVS (CVR 40357092 ) | -16.644 | -16.444 | 0 % | 21 % | |
90 | NORDIA PHARMACEUTICAL COMPANY ApS (CVR 18866692 ) | 4.409 | -28.013 | 0 % | 0 % | |
91 | DECUMED ApS (CVR 32083560 ) | -6.284 | -40.161 | 1 | 0 % | 3 % |
92 | Endothel Pharma ApS (CVR 37988936 ) | -36.111 | -40.424 | 50 % | 5 % | |
93 | ADJECT ApS (CVR 32661599 ) | -74.948 | 1 | 50 % | 11 % | |
94 | Vanquish Innovation ApS (CVR 38611232 ) | -116.383 | -75.782 | 0 % | 0 % | |
95 | VetInject A/S (CVR 36949740 ) | -180.082 | -90.371 | 25 % | 8 % | |
96 | KovaLine International ApS (CVR 37821985 ) | -138.923 | -109.982 | 0 % | 13 % | |
97 | Lionheart Pharmaceuticals ApS (CVR 37138789 ) | -77.923 | -110.485 | 0 % | 0 % | |
98 | DANCANN PHARMA A/S (CVR 39426005 ) | -125.452 | -125.451 | 1 | 0 % | 0 % |
99 | MIP PHARMA DANMARK ApS (CVR 32886280 ) | -33.370 | -217.169 | 0 % | 14 % | |
100 | STELLARIS PHARMACEUTICALS ApS (CVR 34708215 ) | -112.692 | -219.218 | 100 % | 0 % | |
101 | OrfoNeuro ApS (CVR 37768901 ) | -140.299 | -263.141 | 0 % | 0 % | |
102 | CLINICURO ApS (CVR 33590083 ) | 150.901 | -323.089 | 1 | 0 % | 14 % |
103 | Pharmagen ApS (CVR 36687193 ) | -906.880 | -524.373 | 0 % | 29 % | |
104 | CONRIG PHARMA ApS (CVR 33373236 ) | -398.031 | -594.571 | 0 % | 0 % | |
105 | SALIXIN A/S (CVR 33776748 ) | -973.614 | -813.631 | 3 | 0 % | 8 % |
106 | Bactolife ApS (CVR 38879073 ) | -1.645.615 | -1.235.017 | 1 | 20 % | 7 % |
107 | Draupnir Bio ApS (CVR 38546880 ) | -2.117.554 | -1.788.946 | 50 % | 0 % | |
108 | Ebumab ApS (CVR 39859173 ) | -2.053.509 | -2.003.509 | 0 % | 1 % | |
109 | Dana Genetic A/S (CVR 37298182 ) | -490.214 | -2.141.594 | 0 % | 15 % | |
110 | MULTIMERICS ApS (CVR 31603390 ) | 18.807 | -2.456.116 | 67 % | 0 % | |
111 | HYPOSKIN ApS (CVR 34226083 ) | -205.916 | -2.793.119 | 0 % | 2 % | |
112 | BLUSENSE DIAGNOSTICS APS (CVR 36059184 ) | -27.957.000 | -8.551.000 | 35 | 0 % | 7 % |
113 | SYNACT PHARMA ApS (CVR 34459975 ) | -9.826.308 | -21.827.046 | 0 % | 4 % | |
114 | DUNE MEDICARE ApS (CVR 33377541 ) | -6.020.269 | -24.560.194 | 50 % | 0 % | |
115 | Ascendis Pharma Growth Disorders A/S (CVR 32323677 ) *) Valuta: EUR | -19.025.880 | -57.385.336 | 33 % | 9 % | |
116 | ASCENDIS PHARMA BONE DISEASES A/S (CVR 32323596 ) *) Valuta: EUR | -28.817.684 | -73.847.129 | 33 % | 9 % | |
117 | Oncology Venture Product Development ApS (CVR 34623562 ) | -33.965.000 | -128.504.000 | 7 | 0 % | 4 % |
118 | FARMACEUTISK LABORATORIUM FERRING A/S (CVR 62664819 ) | 119.000 | -202.324.000 | 33 % | 0 % | |
119 | Ascendis Pharma Endocrinology Division A/S (CVR 32323537 ) *) Valuta: EUR | -95.044.994 | -302.791.193 | 33 % | 9 % |